Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
New Frontiers Open Up in Molecular Diagnostics
Personalized Tests and Treatments Are Heightened by Repertoire of Advances in DNA-Based Technologies
- Few clinical niches are currently spared from the reach of novel genomic technologies. Molecular analysis technologies enable the parsing of biological pathways with previously unattainable granularity. Stratifying patient populations based on their genetic markers is becoming a clinical reality. In the near future, some of these markers may become ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.